Accedi a banche dati online | Convegnodetail
Anteprima di stampa
 
 

ARDS Drug Development Summit

Evvnt Promotion / evvnt
-
13.07.2021 - 15.07.2021  Virtual
Time: 7:55 am - 3:00 pm
 
Temi della conferenza
The coronavirus pandemic has catapulted ARDS into the limelight and offered a once in a lifetime opportunity to meaningfully study large patient populations with homogenous disease – revolutionizing the notoriously challenging drug development landscape and widening the window of therapeutic opportunity to treat ARDS for the first time ever.
Professional congress organizer (PCO)
Hanson Wade
Annotazioni
Brochure: https://go.evvnt.com/745323-3?pid=4832

Speakers: Eric Jenkins, Senior Medical Director, Athersys, Melanie Kelly, Chief Scientific Officer, Tetra Biopharma and more
 

Informazioni ed Iscrizioni:

https://go.evvnt.com/745323-0?pid=4832
Ms. Kaltrina Kastrati
 
Categorie
Medicina General, Sanità Pubblica (Public Health)
Lingua
Inglese
Quote del Congresso
Conference + Workshops Day - Industry Pricing: USD 2697.00, Conference Only - Industry Pricing: USD 1999.00, Conference + Workshops Day - Academic Pricing: USD 2397.00, Conference Only - Academic Pricing: USD 1799.00
Contatto organizzatori
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Noi, Going International, siamo un’azienda che si è scelta come obiettivo di rendere acessibile la formazione a una grandissima quantità di persone, oltrepassanddo i confini geografici e sociali."

Alumni Club Medizinische Universität WienÄrzte der WeltÖsterreichische Akademie der ÄrzteÖsterreichische Gesellschaft für Public HealthÄrztekammer für WienCenter of ExcellenceHelix - Forschung & Beratung WienAMREF - African Medical and Research Foundation